Singapore markets open in 8 hours 12 minutes
Straits Times Index
3,367.90 +29.33 (+0.88%) S&P 500
5,479.26 +4.17 (+0.08%) Dow
39,114.01 -55.51 (-0.14%) Nasdaq
17,923.61 +44.31 (+0.25%) Bitcoin USD
61,917.34 -1,148.75 (-1.82%) CMC Crypto 200
1,307.31 -37.19 (-2.77%)
MAIA Biotechnology, Inc. (MAIA)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:45PM EDT. Market open.
| Previous close | 3.4400 |
| Open | 3.4600 |
| Bid | 3.4000 x 2900 |
| Ask | 3.4500 x 800 |
| Day's range | 3.3100 - 3.6000 |
| 52-week range | 0.8200 - 5.9900 |
| Volume | |
| Avg. volume | 364,553 |
| Market cap | 73.993M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
CHICAGO, June 07, 2024--MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
- Business Wire
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
CHICAGO, June 06, 2024--MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
- Business Wire
MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
CHICAGO, June 04, 2024--MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
© 2024 Yahoo. All rights reserved.